DuPont Changing Labels For Antiseptic Products To Comply With FDA Warning
This article was originally published in The Tan Sheet
Executive Summary
DuPont plans by the end of June to comply with FDA's warning to change the labels for its RelyOn antiseptic spray and hand-wipe products that include disease claims not approved in a pending monograph for OTC health care antiseptics or in the topical antifungal drug products monograph
You may also be interested in...
FDA Budget Reaffirms Commitment To OTCs, Reduces Supplement Programs
FDA hopes to increase the number of over-the-counter drugs on the market as part of its long-term goal to provide consumers with safe, effective and affordable drugs, the agency states in its fiscal year 2007 budget request presentation
Antiseptic Products “Not Effective” In Reducing Skin Infection – FDA
No available evidence demonstrates that consumer antiseptic products reduce the risk of skin infection and such indications should not be included in the drug monograph, Office of Nonprescription Products reviewers say
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”